676 related articles for article (PubMed ID: 16769798)
1. Successful allogeneic hemopoietic stem cell transplantation in a child who had anhidrotic ectodermal dysplasia with immunodeficiency.
Dupuis-Girod S; Cancrini C; Le Deist F; Palma P; Bodemer C; Puel A; Livadiotti S; Picard C; Bossuyt X; Rossi P; Fischer A; Casanova JL
Pediatrics; 2006 Jul; 118(1):e205-11. PubMed ID: 16769798
[TBL] [Abstract][Full Text] [Related]
2. Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency.
Fish JD; Duerst RE; Gelfand EW; Orange JS; Bunin N
Bone Marrow Transplant; 2009 Feb; 43(3):217-21. PubMed ID: 18794870
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia.
Niehues T; Reichenbach J; Neubert J; Gudowius S; Puel A; Horneff G; Lainka E; Dirksen U; Schroten H; Döffinger R; Casanova JL; Wahn V
J Allergy Clin Immunol; 2004 Dec; 114(6):1456-62. PubMed ID: 15577852
[TBL] [Abstract][Full Text] [Related]
4. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia.
Orange JS; Levy O; Brodeur SR; Krzewski K; Roy RM; Niemela JE; Fleisher TA; Bonilla FA; Geha RS
J Allergy Clin Immunol; 2004 Sep; 114(3):650-6. PubMed ID: 15356572
[TBL] [Abstract][Full Text] [Related]
5. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
Buckley RH; Schiff SE; Sampson HA; Schiff RI; Markert ML; Knutsen AP; Hershfield MS; Huang AT; Mickey GH; Ward FE
J Immunol; 1986 Apr; 136(7):2398-407. PubMed ID: 2869085
[TBL] [Abstract][Full Text] [Related]
6. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency.
Courtois G; Smahi A; Reichenbach J; Döffinger R; Cancrini C; Bonnet M; Puel A; Chable-Bessia C; Yamaoka S; Feinberg J; Dupuis-Girod S; Bodemer C; Livadiotti S; Novelli F; Rossi P; Fischer A; Israël A; Munnich A; Le Deist F; Casanova JL
J Clin Invest; 2003 Oct; 112(7):1108-15. PubMed ID: 14523047
[TBL] [Abstract][Full Text] [Related]
7. Anhidrotic ectodermal dysplasia and immunodeficiency: the role of NEMO.
Carrol ED; Gennery AR; Flood TJ; Spickett GP; Abinun M
Arch Dis Child; 2003 Apr; 88(4):340-1. PubMed ID: 12651765
[TBL] [Abstract][Full Text] [Related]
8. Autosomal dominant anhidrotic ectodermal dysplasia with immunodeficiency caused by a novel NFKBIA mutation, p.Ser36Tyr, presents with mild ectodermal dysplasia and non-infectious systemic inflammation.
Yoshioka T; Nishikomori R; Hara J; Okada K; Hashii Y; Okafuji I; Nodomi S; Kawai T; Izawa K; Ohnishi H; Yasumi T; Nakahata T; Heike T
J Clin Immunol; 2013 Oct; 33(7):1165-74. PubMed ID: 23864385
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of genotype-phenotype correlation in autosomal dominant anhidrotic ectodermal dysplasia with immune deficiency.
Petersheim D; Massaad MJ; Lee S; Scarselli A; Cancrini C; Moriya K; Sasahara Y; Lankester AC; Dorsey M; Di Giovanni D; Bezrodnik L; Ohnishi H; Nishikomori R; Tanita K; Kanegane H; Morio T; Gelfand EW; Jain A; Secord E; Picard C; Casanova JL; Albert MH; Torgerson TR; Geha RS
J Allergy Clin Immunol; 2018 Mar; 141(3):1060-1073.e3. PubMed ID: 28629746
[TBL] [Abstract][Full Text] [Related]
10. Transient hemophagocytosis with deficient cellular cytotoxicity, monoclonal immunoglobulin M gammopathy, increased T-cell numbers, and hypomorphic NEMO mutation.
Pachlopnik Schmid JM; Junge SA; Hossle JP; Schneider EM; Roosnek E; Seger RA; Gungor T
Pediatrics; 2006 May; 117(5):e1049-56. PubMed ID: 16636116
[TBL] [Abstract][Full Text] [Related]
11. Heritable defects of the human TLR signalling pathways.
Puel A; Yang K; Ku CL; von Bernuth H; Bustamante J; Santos OF; Lawrence T; Chang HH; Al-Mousa H; Picard C; Casanova JL
J Endotoxin Res; 2005; 11(4):220-4. PubMed ID: 16176658
[TBL] [Abstract][Full Text] [Related]
12. Correction of immunodeficiency associated with NEMO mutation by umbilical cord blood transplantation using a reduced-intensity conditioning regimen.
Tono C; Takahashi Y; Terui K; Sasaki S; Kamio T; Tandai S; Sato T; Kudo K; Toki T; Tachibana N; Yoshioka T; Nakahata T; Morio T; Nishikomori R; Ito E
Bone Marrow Transplant; 2007 Jun; 39(12):801-4. PubMed ID: 17417663
[No Abstract] [Full Text] [Related]
13. Successful Allogeneic Stem Cell Transplantation in Nuclear Factor-Kappa B Essential Modulator Deficiency Syndrome After Treosulfan-Based Conditioning: A Case Report.
Martuszewski A; Paluszkiewicz P; Sierżęga-Staykov K; Wawrzyniak-Dzierżek E; Salamonowicz-Bodzioch M; Frączkiewicz J; Janeczko-Czarnecka M; Mielcarek-Siedziuk M; Nowak M; Dąbrowska-Leonik N; Wolska-Kuśnierz B; Gul K; Bąbol-Pokora K; Młynarski W; Kałwak K; Ussowicz M
Transplant Proc; 2020 Mar; 52(2):647-652. PubMed ID: 32035679
[TBL] [Abstract][Full Text] [Related]
14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-kappaB essential modulator deficiency.
Pai SY; Levy O; Jabara HH; Glickman JN; Stoler-Barak L; Sachs J; Nurko S; Orange JS; Geha RS
J Allergy Clin Immunol; 2008 Dec; 122(6):1113-1118.e1. PubMed ID: 18851875
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment in anhidrotic ectodermal dysplasia with immunodeficiency.
Kawai T; Nishikomori R; Heike T
Allergol Int; 2012 Jun; 61(2):207-17. PubMed ID: 22635013
[TBL] [Abstract][Full Text] [Related]
17. Successful related umbilical cord blood transplantation for graft failure following T cell-depleted non-identical bone marrow transplantation in a child with major histocompatibility complex class II deficiency.
Bonduel M; Pozo A; Zelazko M; Raslawski E; Delfino S; Rossi J; Figueroa C; Sackmann Muriel F
Bone Marrow Transplant; 1999 Aug; 24(4):437-40. PubMed ID: 10467337
[TBL] [Abstract][Full Text] [Related]
18. Solution structure of NEMO zinc finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation.
Cordier F; Vinolo E; Véron M; Delepierre M; Agou F
J Mol Biol; 2008 Apr; 377(5):1419-32. PubMed ID: 18313693
[TBL] [Abstract][Full Text] [Related]
19. ORAI1 mutations abolishing store-operated Ca
Lian J; Cuk M; Kahlfuss S; Kozhaya L; Vaeth M; Rieux-Laucat F; Picard C; Benson MJ; Jakovcevic A; Bilic K; Martinac I; Stathopulos P; Kacskovics I; Vraetz T; Speckmann C; Ehl S; Issekutz T; Unutmaz D; Feske S
J Allergy Clin Immunol; 2018 Oct; 142(4):1297-1310.e11. PubMed ID: 29155098
[TBL] [Abstract][Full Text] [Related]
20. Novel hypomorphic mutation in IKBKG impairs NEMO-ubiquitylation causing ectodermal dysplasia, immunodeficiency, incontinentia pigmenti, and immune thrombocytopenic purpura.
Ramírez-Alejo N; Alcántara-Montiel JC; Yamazaki-Nakashimada M; Duran-McKinster C; Valenzuela-León P; Rivas-Larrauri F; Cedillo-Barrón L; Hernández-Rivas R; Santos-Argumedo L
Clin Immunol; 2015 Oct; 160(2):163-71. PubMed ID: 26117626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
